Role of 18F-FDG PET-CT in Postoperative Surveillance of Colorectal Cancer Patients with Different Carcinoembryonic Antigen Concentrations
Y. Zhang,G. Zhang,M. Hu,X. Zhang,L. Kong,J. Yu
DOI: https://doi.org/10.1016/j.ijrobp.2014.05.1244
2014-01-01
Abstract:Purpose/Objective(s)To evaluate the diagnostic performance of Fluorine-18 (18F) fluorodeoxyglucose (FDG) positron emission tomography (PET)/computerized tomography (CT) in surveillance of postoperative colorectal cancer (CRC) patients as compared with CT and to investigate the role of FDG PET/CT in patients with different carcinoembryonic antigen (CEA) concentrations.Materials/MethodsThe study enrolled in one hundred and thirteen postoperative CRC patients who were confirmed by histopathology and suspected recurrence or metastasis based on routine examination including serum CEA examination and CT scan. All patients received FDG PET/CT scan within one week after routine examination. Final diagnoses were confirmed by histological confirmation or clinical follow-up over at least six months.ResultsThe sensitivity, specificity, and accuracy of FDG PET/CT were 95.1%, 80.8% and 91.6% in the case-based analysis and 94.3%, 81.4% and 92% in the lesion-based analysis. The sensitivity and accuracy of FDG PET/CT in diagnosis significantly differed from CT in both case-based and lesion-based analyses (P<0.05). The sensitivity, specificity, and accuracy of both imaging techniques were increased with the CEA level. In case-based analysis, the sensitivity, specificity, and accuracy of PET/CT in patients with abnormal CEA level were 97.1%, 81.6%, and 96.8% and didn’t significantly differ from the patients with normal CEA level. In lesion-based analysis, the sensitivity, specificity, and accuracy of FDG PET/CT in abnormal CEA group were 96.2%, 81.2%, 93.3% and the sensitivity and accuracy significantly differed from that of the normal CEA group (p<0.05). FDG PET/CT changed the management in 45.3% patients with positive scans.ConclusionsThe FDG PET/CT showed superior value in surveillance of postoperative CRC patients. For patients with suspicious recurrence or metastasis based on a routine examination, PET/CT was an excellent option in the follow-up of CRC patients even when CEA is normal. Purpose/Objective(s)To evaluate the diagnostic performance of Fluorine-18 (18F) fluorodeoxyglucose (FDG) positron emission tomography (PET)/computerized tomography (CT) in surveillance of postoperative colorectal cancer (CRC) patients as compared with CT and to investigate the role of FDG PET/CT in patients with different carcinoembryonic antigen (CEA) concentrations. To evaluate the diagnostic performance of Fluorine-18 (18F) fluorodeoxyglucose (FDG) positron emission tomography (PET)/computerized tomography (CT) in surveillance of postoperative colorectal cancer (CRC) patients as compared with CT and to investigate the role of FDG PET/CT in patients with different carcinoembryonic antigen (CEA) concentrations. Materials/MethodsThe study enrolled in one hundred and thirteen postoperative CRC patients who were confirmed by histopathology and suspected recurrence or metastasis based on routine examination including serum CEA examination and CT scan. All patients received FDG PET/CT scan within one week after routine examination. Final diagnoses were confirmed by histological confirmation or clinical follow-up over at least six months. The study enrolled in one hundred and thirteen postoperative CRC patients who were confirmed by histopathology and suspected recurrence or metastasis based on routine examination including serum CEA examination and CT scan. All patients received FDG PET/CT scan within one week after routine examination. Final diagnoses were confirmed by histological confirmation or clinical follow-up over at least six months. ResultsThe sensitivity, specificity, and accuracy of FDG PET/CT were 95.1%, 80.8% and 91.6% in the case-based analysis and 94.3%, 81.4% and 92% in the lesion-based analysis. The sensitivity and accuracy of FDG PET/CT in diagnosis significantly differed from CT in both case-based and lesion-based analyses (P<0.05). The sensitivity, specificity, and accuracy of both imaging techniques were increased with the CEA level. In case-based analysis, the sensitivity, specificity, and accuracy of PET/CT in patients with abnormal CEA level were 97.1%, 81.6%, and 96.8% and didn’t significantly differ from the patients with normal CEA level. In lesion-based analysis, the sensitivity, specificity, and accuracy of FDG PET/CT in abnormal CEA group were 96.2%, 81.2%, 93.3% and the sensitivity and accuracy significantly differed from that of the normal CEA group (p<0.05). FDG PET/CT changed the management in 45.3% patients with positive scans. The sensitivity, specificity, and accuracy of FDG PET/CT were 95.1%, 80.8% and 91.6% in the case-based analysis and 94.3%, 81.4% and 92% in the lesion-based analysis. The sensitivity and accuracy of FDG PET/CT in diagnosis significantly differed from CT in both case-based and lesion-based analyses (P<0.05). The sensitivity, specificity, and accuracy of both imaging techniques were increased with the CEA level. In case-based analysis, the sensitivity, specificity, and accuracy of PET/CT in patients with abnormal CEA level were 97.1%, 81.6%, and 96.8% and didn’t significantly differ from the patients with normal CEA level. In lesion-based analysis, the sensitivity, specificity, and accuracy of FDG PET/CT in abnormal CEA group were 96.2%, 81.2%, 93.3% and the sensitivity and accuracy significantly differed from that of the normal CEA group (p<0.05). FDG PET/CT changed the management in 45.3% patients with positive scans. ConclusionsThe FDG PET/CT showed superior value in surveillance of postoperative CRC patients. For patients with suspicious recurrence or metastasis based on a routine examination, PET/CT was an excellent option in the follow-up of CRC patients even when CEA is normal. The FDG PET/CT showed superior value in surveillance of postoperative CRC patients. For patients with suspicious recurrence or metastasis based on a routine examination, PET/CT was an excellent option in the follow-up of CRC patients even when CEA is normal.